Chronic Rhinosinusitis With Nasal Polyps clinical trials

Explore recruiting chronic rhinosinusitis with nasal polyps clinical trials.

Recruiting chronic rhinosinusitis with nasal polyps studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Chronic Rhinosinusitis With Nasal Polyps trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

English Title: Tapering of biologics in CRSwNP Subtitle: Tapering of Mepolizumab or Dupilumab after 12 months of complete or partial disease control in patients with severe chronic rhinosinusitis with nasal polyposis – a national Danish RCT.

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 2, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Efficacy and Safety of Verekitug (UPB-101) in Participants with Chronic Rhinosinusitis with Nasal Polyps on a Background of Nasal Corticosteroids (VIBRANT)

Germany, Czechia, Spain, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Direct comparison of Tezepelumab and Dupilumab in CRSwNP in a real world setting

Austria

Therapeutic use (Phase IV) EU CTIS Study details

A randomized, double blind, placebo controlled, parallel group, 52week Phase 3 trial to investigate the efficacy, safety, and tolerability of itepekimab in adult participants with inadequately-controlled chronic rhinosinusitis with nasal polyps

Poland, Denmark, France, Romania, Netherlands, Germany +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A single-arm extension study to investigate the long-term safety, tolerability, and efficacy of lunsekimig in adult participants with inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) who completed a previous lunsekimig CRSwNP clinical study

Bulgaria, Poland, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

A randomized, double blind, placebo controlled, parallel group, 52week Phase 3 trial to investigate the efficacy, safety, and tolerability of itepekimab in adult participants with inadequately-controlled chronic rhinosinusitis with nasal polyps

Sweden, Portugal, Germany, Poland, Hungary, Netherlands +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Chronic Rhinosinusitis With Nasal Polyps trials by city

Chronic Rhinosinusitis With Nasal Polyps clinical trials

Recruiting chronic rhinosinusitis with nasal polyps studies right now

A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab

Tapering of Biologics in Chronic Rhinosinusitis With Nasal Polyps

Complete Remission After Treatment With Biologics for Nasal Polyps

Effect of Full-House ESS With Nasopharyngeal Lymphoid Tissue Ablation on Nasal Polyps

Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP

Efficacy and Safety of SHR-1905 Injection in Subjects With Chronic Rhinosinusitis With Nasal Polyps

In-clinic Endoscopic Polypectomy for Chronic Sinusitis With Nasal Polyps

Biologics in Chronic Rhinosinusitis With Nasal Polyposis

Upper Airway Inflammation and Olfaction: Mechanisms of Loss and Recovery

Real-Time Diagnosis of Eosinophilic Nasal Polyps Using High-Sensitivity Spectroscopy

Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps

A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With or Without Comorbid Asthma

Also recruiting in Europe

English Title: Tapering of biologics in CRSwNP Subtitle: Tapering of Mepolizumab or Dupilumab after 12 months of complete or partial disease control in patients with severe chronic rhinosinusitis with nasal polyposis – a national Danish RCT.

A Phase 2, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Efficacy and Safety of Verekitug (UPB-101) in Participants with Chronic Rhinosinusitis with Nasal Polyps on a Background of Nasal Corticosteroids (VIBRANT)

Direct comparison of Tezepelumab and Dupilumab in CRSwNP in a real world setting

A randomized, double blind, placebo controlled, parallel group, 52week Phase 3 trial to investigate the efficacy, safety, and tolerability of itepekimab in adult participants with inadequately-controlled chronic rhinosinusitis with nasal polyps

A single-arm extension study to investigate the long-term safety, tolerability, and efficacy of lunsekimig in adult participants with inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) who completed a previous lunsekimig CRSwNP clinical study

A randomized, double blind, placebo controlled, parallel group, 52week Phase 3 trial to investigate the efficacy, safety, and tolerability of itepekimab in adult participants with inadequately-controlled chronic rhinosinusitis with nasal polyps

Chronic Rhinosinusitis With Nasal Polyps trials by city

Other conditions

Chronic Rhinosinusitis With Nasal Polyps clinical trials

Recruiting chronic rhinosinusitis with nasal polyps studies right now

A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab

Tapering of Biologics in Chronic Rhinosinusitis With Nasal Polyps

Complete Remission After Treatment With Biologics for Nasal Polyps

Effect of Full-House ESS With Nasopharyngeal Lymphoid Tissue Ablation on Nasal Polyps

Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP

Efficacy and Safety of SHR-1905 Injection in Subjects With Chronic Rhinosinusitis With Nasal Polyps

In-clinic Endoscopic Polypectomy for Chronic Sinusitis With Nasal Polyps

Biologics in Chronic Rhinosinusitis With Nasal Polyposis

Upper Airway Inflammation and Olfaction: Mechanisms of Loss and Recovery

Real-Time Diagnosis of Eosinophilic Nasal Polyps Using High-Sensitivity Spectroscopy

Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps

A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With or Without Comorbid Asthma

Also recruiting in Europe

English Title: Tapering of biologics in CRSwNP Subtitle: Tapering of Mepolizumab or Dupilumab after 12 months of complete or partial disease control in patients with severe chronic rhinosinusitis with nasal polyposis – a national Danish RCT.

A Phase 2, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Efficacy and Safety of Verekitug (UPB-101) in Participants with Chronic Rhinosinusitis with Nasal Polyps on a Background of Nasal Corticosteroids (VIBRANT)

Direct comparison of Tezepelumab and Dupilumab in CRSwNP in a real world setting

A randomized, double blind, placebo controlled, parallel group, 52­week Phase 3 trial to investigate the efficacy, safety, and tolerability of itepekimab in adult participants with inadequately-controlled chronic rhinosinusitis with nasal polyps

A single-arm extension study to investigate the long-term safety, tolerability, and efficacy of lunsekimig in adult participants with inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) who completed a previous lunsekimig CRSwNP clinical study

A randomized, double blind, placebo controlled, parallel group, 52­week Phase 3 trial to investigate the efficacy, safety, and tolerability of itepekimab in adult participants with inadequately-controlled chronic rhinosinusitis with nasal polyps

Chronic Rhinosinusitis With Nasal Polyps trials by city

Other conditions

A randomized, double blind, placebo controlled, parallel group, 52week Phase 3 trial to investigate the efficacy, safety, and tolerability of itepekimab in adult participants with inadequately-controlled chronic rhinosinusitis with nasal polyps

A randomized, double blind, placebo controlled, parallel group, 52week Phase 3 trial to investigate the efficacy, safety, and tolerability of itepekimab in adult participants with inadequately-controlled chronic rhinosinusitis with nasal polyps